Concern raised over persistent gaps in essential medicines

In brief

Millions of people in low- and middle-income countries continue to face barriers to accessing essential medicines, with affordability, availability and inadequate healthcare systems limiting the benefits of pharmaceutical research and innovation. The findings are contained in the 2026 Access to Medicine Index, which shows that although pharmaceutical companies are increasingly incorporating access considerations…